Novo Nordisk

Corporate restructuring SK Inc. in talks to sell Pharmteco’s US CDMO plant to Novo Nordisk

SK Inc., the holding and investment company of SK Group, South Korea’s second-largest conglomerate, is negotiating to sell a major asset of it...

Bio & Pharma Handok gets Biocon's obesity drug exclusive distribution in S.Korea

South Korean pharmaceutical company Handok Inc. announced on Friday that it signed an exclusive domestic sales and distribution agreement with India...

Bio & Pharma Kakao Healthcare signs agreement with Novo Nordisk for digital service

Kakao Healthcare Corp., a digital healthcare platform unit of South Korea's Kakao Corp., announced that it has signed on Tuesday a business agreemen...